NCT01784718No Longer Available不适用

Compassionate Use of Buphenyl® in the Treatment of Byler's Disease

University of Pittsburgh0 个研究点开始时间: 2013年2月6日最近更新: 2013年2月6日

研究概览

简要总结

This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

研究设计

研究类型: Expanded Access

入排标准

年龄范围: 1 Year 至 —（Child, Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•Byler Disease
•Cholestasis unresponsive to pharmacologic therapy

排除标准

•Allergy/Hypersensitivity to Buphenyl

研究者

发起方

University of Pittsburgh

申办方类型

Other

责任方

Sponsor

相似试验

已完成

1 期

Safety and Tolerability of Phenylbutyrate in Inclusion Body MyositisInclusion Body MyositisSporadic Inclusion Body Myositis

NCT04421677University of Kansas Medical Center10

终止

4 期

Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED)Hepatitis C, Chronic

NCT00279565Indivior Inc.128

已完成

3 期

Safety and Efficacy of Buprenorphine Transdermal System in Subjects With Moderate to Severe Osteoarthritis of Hip or KneeOsteoarthritis

NCT00313846Purdue Pharma LP529

已完成

2 期

Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment MenSexual Dysfunctions, PsychologicalErectile DysfunctionsHypoactive Sexual Desire Disorder

NCT02593396University of Malaya80

已完成

1 期

Use of Busulfan as Conditioning Agent for a Second Stem Cell TransplantGranulomatous DiseaseChronic

NCT00092937National Institute of Allergy and Infectious Diseases (NIAID)2